Integrated Advisors Network LLC Sorrento Therapeutics, Inc. Transaction History

Integrated Advisors Network LLC

  • $2.08 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023
BUY
$0.74 - $1.83 $12,532 - $30,992
16,936 New
16,936 $15,000
Q2 2022

Aug 12, 2022
BUY
$1.24 - $2.33 $744 - $1,398
600 Added 3.67%
16,936 $34,000
Q1 2022

May 02, 2022
BUY
$2.0 - $4.9 $672 - $1,646
336 Added 2.1%
16,336 $38,000
Q4 2021

Feb 14, 2022
BUY
$4.65 - $7.23 $13,950 - $21,690
3,000 Added 23.08%
16,000 $74,000
Q2 2021

Aug 06, 2021
SELL
$6.35 - $10.0 $25,400 - $40,000
-4,000 Reduced 23.53%
13,000 $126,000
Q1 2021

May 17, 2021
BUY
$7.03 - $16.51 $119,510 - $280,670
17,000 New
17,000 $141,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email